Clinical Trial Update: Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study evaluating ivermectin 1% cream for facial rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Rosacea

Drugs mentioned

• Ivermectin Cream 1% (ivermectin)

Snippet

Sponsor: Zydus Worldwide DMCC | Conditions: Facial Rosacea | Phase 3 | Status: COMPLETED